AP Aboobacker Musliyar praises Saudi king, condemns Madinah terror attack

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.

Bengaluru, May 20: Karnataka State Road Transport Corporation (KSRTC) had to confront an unprecedented situation as there was a commotion at bus stands in various parts of the state due to the mad rush of passengers.

Deputy Chief Minister Laxman Savadi, who is in charge of the transport department, admitted that there were some shortcomings in the arrangements. He, however, was confident that things would improve from Wednesday.

As against the dearth of passengers in the bus stands in Bengaluru a day ago, Wednesday witnessed an overwhelming crowd blaming BMTC authorities for not providing enough buses for all the destinations on time.

Some of the employees who were asked to report to duty before certain time were facing difficulty in reaching the office in the absence of bus despite having daily pass and arriving at the stand well in advance.

Authorities were finding it difficult to convince the public as a bus could ferry only 35 passengers at a time which was way less than the demand.

Mangaluru, Jul 24: Low-cost airline IndiGo airlines would be operating between Mumbai and Mangaluru four days a week - Monday, Wednesday, Friday and Sunday. The operation will begin today (July 24).

The flight will take off from Mumbai at 9.30 am and will land at Mangaluru International Airport at 11.00 am. 

The flight will take off from Mangaluru at 11.40 am and will reach Mumbai at 1.15 pm. To avail the flights for Mangaluru, passengers can report to Terminal T2 in Mumbai.

Before boarding the flight, a standard procedure regarding quarantine regulation has been issued. The passengers boarding the flight from Mumbai will have to undergo thermal screening at the airport. The airport officials will also be required to apply a quarantine stamp on the passengers.

The airline will be required to provide a detailed list of passengers arriving, along with flight information, arrival time, mobile number of the passengers and their residential addresses and share these with the nodal officer.

It is mandatory for the passengers to download Aarogya Setu app. In addition to this, passengers intending to exit Mumbai within seven days of the arrival should be able to produce a confirmed ticket for onward/return journey to get quarantine exemption.

Domestic passengers will have to undergo 14 days of home quarantine. However, all domestic passengers intending to exit Mumbai within seven days of the arrival will be exempted from quarantine, provided they are able to produce a confirmed ticket for onward/return journey.